India is close to approving a genetically edited variety of mustard, which offers better nutrition and disease resistance ...

The healthcare industry, on the other hand, has been a bit of a laggard. Could they keep the momentum going in 2026? Let's ...

India's first gene-edited sheep recently turned a year old and researchers who developed it say it's doing well. Born on 16 ...

Earlier in the week, ARK purchased 10,353 shares of CRISPR on Wednesday, valued at $584,530, and 43,333 shares on Tuesday, totaling $2,509,414. This consistent buying pattern suggests a strong ...

When systems are built for hundreds of millions of people, efficiency becomes mandatory, inclusion critical, and cost ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made another round of trades on Christmas Eve, December 24, sticking ...

Cathie Wood's ARK Invest made additional portfolio adjustments, continuing moves seen in prior sessions. The firm increased ...

The findings might overturn a widely held belief that only females pose a disease risk to people, though more research is ...

SRINAGAR: SKUAST-K has secured a major scientific windfall, winning eight high-impact R&D projects worth Rs 7.22 crore from the Anusandhan National Research Foundation (ANRF). The funding, awarded ...

Advances delivered what may feel like medical miracles, including the first bladder transplant, a lifesaving personalized ...

Immense progress in gene editing, drug discovery and conservation are just some of the reasons to be cheerful about 2025 ...

Scientists mapped hidden DNA switches in brain support cells to understand how gene control may influence Alzheimer’s disease ...